Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 22% ± 6% | |
endothelial cell | 7 studies | 22% ± 6% | |
pericyte | 5 studies | 18% ± 3% | |
astrocyte | 5 studies | 20% ± 5% | |
smooth muscle cell | 4 studies | 17% ± 1% | |
epithelial cell | 4 studies | 42% ± 16% | |
glutamatergic neuron | 4 studies | 37% ± 16% | |
basal cell | 4 studies | 25% ± 9% | |
myofibroblast cell | 3 studies | 16% ± 1% | |
GABAergic neuron | 3 studies | 37% ± 10% | |
abnormal cell | 3 studies | 23% ± 6% | |
macrophage | 3 studies | 16% ± 1% | |
oligodendrocyte | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5901.13 | 1445 / 1445 | 100% | 34.16 | 183 / 183 |
prostate | 100% | 7190.96 | 245 / 245 | 100% | 50.84 | 502 / 502 |
stomach | 100% | 4409.13 | 359 / 359 | 100% | 31.06 | 286 / 286 |
lung | 100% | 5466.47 | 578 / 578 | 100% | 37.78 | 1154 / 1155 |
breast | 100% | 5952.55 | 459 / 459 | 100% | 42.74 | 1117 / 1118 |
bladder | 100% | 6737.38 | 21 / 21 | 100% | 37.56 | 502 / 504 |
skin | 100% | 6731.96 | 1809 / 1809 | 100% | 44.24 | 470 / 472 |
ovary | 100% | 7406.48 | 180 / 180 | 100% | 53.14 | 428 / 430 |
intestine | 100% | 5522.76 | 966 / 966 | 99% | 31.54 | 524 / 527 |
thymus | 100% | 6945.07 | 653 / 653 | 99% | 39.74 | 601 / 605 |
brain | 99% | 3608.05 | 2621 / 2642 | 100% | 36.81 | 705 / 705 |
pancreas | 100% | 3560.94 | 328 / 328 | 99% | 30.41 | 176 / 178 |
kidney | 100% | 4629.67 | 89 / 89 | 98% | 51.37 | 884 / 901 |
uterus | 100% | 7414.80 | 170 / 170 | 96% | 34.37 | 441 / 459 |
adrenal gland | 100% | 6420.17 | 258 / 258 | 93% | 23.69 | 213 / 230 |
liver | 100% | 2836.57 | 225 / 226 | 92% | 18.87 | 375 / 406 |
adipose | 100% | 5789.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5717.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.87 | 29 / 29 |
muscle | 100% | 4473.09 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4595.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.13 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 35.15 | 79 / 80 |
heart | 98% | 3563.44 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 2956.70 | 823 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LRRC41 |
Protein name | Leucine-rich repeat-containing protein 41 Leucine-rich repeat-containing protein 41 (Protein Muf1) Leucine rich repeat containing 41 |
Synonyms | MUF1 PP7759 |
Description | FUNCTION: Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
Accessions | ENST00000615587.4 A0A087WTU1 A0A087X0S7 A0A0B4J2G4 ENST00000472710.2 ENST00000343304.10 [Q15345-2] A0A087WTI9 ENST00000617190.5 [Q15345-2] Q562F1 Q15345 ENST00000498402.2 ENST00000496156.5 |